Harvard (company)

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...




Further reading


Documentaries, videos and podcasts





Alex Bellos
October 19, 2020
the Guardian
Photograph: C Squared Studios/Getty Images
Beth Mole
October 12, 2020
Ars Technica
High death rates, large death toll, mental health crisis, and economic ruin.
Emily Pontecorvo
October 1, 2020
Hint: They aren't stoping at fossil fuels.
Seema K. Shah
August 30, 2020
Scientific American
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.
August 23, 2020
Houston Chronicle
NEW DELHI, India (AP) - In June, India began using cheaper, faster but less accurate tests to scale up testing for the coronavirus - a strategy that the United States is now considering. These rapid tests boosted India's testing levels nearly five-fold within two months. But government numbers suggest some parts of the country might have become over reliant on the faster tests, which can miss infections. Experts warn that safely using them requires frequent retesting, something that isn't always happening. Cases surged faster than labs could scale up testing once India's harsh lockdown was relaxed. So far authorities have rationed the use of the more precise molecular tests that detect the genetic code of the virus. But on June 14, India decided to bolster these with faster tests that screen for antigens, or viral proteins. Albeit less accurate, these tests are cheap and yield results in minutes. Most don't require a lab for processing or any specialized equipment or trained personnel. The plan was to rapidly increase testing to identify infected people and prevent them from spreading the virus. Samples tested using both tests increased from 5.6 million in mid-June to 26 million two months later, and nearly a third of all tests conducted daily are now antigen tests, health officials say. But India's experience also highlights the inherent pitfalls of relying too heavily on antigen tests, at the expense of more accurate tests. The danger is that the tests may falsely clear many who are infected with COVID-19, contributing to new spread of the virus in hard-hit areas. Rapid test results can be backstopped with more accurate laboratory tests, but these are slower and expensive. Experts also warn that since the two types of tests vary in accuracy, they need to be interpreted separately to properly assess the...
Emma Campbell
August 14, 2020
Suadela is a program that teaches young girls and women negotiation skills through the use of in-person coaching and a digital platform.
Tyler Cowen | Bloomberg Opinion
August 13, 2020
Universities that open significant branches in India could become among the very best in the world, argues Tyler Cowen.
Associated Press
August 10, 2020
Boston Herald
Racked with anxiety, Lauren Shell needed to talk to her cancer doctor. But she lives at least an hour away and it was the middle of her workday. It was also the middle of a pandemic. The 34-year-old Leominster resident arranged a quick video visit through the app Zoom in May with her doctor. He [...]
Avi Loeb
August 2, 2020
Scientific American
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.
Emma Campbell
July 27, 2020
The startup is taking on the world of fast fashion.
Arlene Weintraub
July 6, 2020
Biogen has formed a research pact with Harvard's Massachusetts Eye and Ear to develop a gene therapy for an inherited form of retinitis pigmentosa caused by mutations in the gene PRPF31. If it succeeds, it could help even more patients than the FDA-approved gene therapy for retinitis pigmentosa, Spark Therapeutics' Luxturna, the researchers believe.
Srividya Kalyanaraman
June 30, 2020
Harvard i-lab's summer venture program has 262 teams and the is fully virtual.
Walter Thompson
June 22, 2020
In the rush to "help now," we cannot throw responsible AI out the window. In fact, in the age of COVID-19 is more important than ever before to understand the unintended consequences and long term effects of the AI systems we create.
Roxanne Khamsi
June 18, 2020
We hoped that Covid-19 would be a seasonal infection. We hoped wrong.
Siobhan Roberts
June 16, 2020
It sometimes seems that automated bots are taking over social media and driving human discourse. But some (real) researchers aren't so sure.
Alex Keown
June 10, 2020
Charles Lieber, the former chair of Harvard University's Chemical Biology Department, was indicted by a federal grand jury this week on two counts of making false statements.
Samie Modak
June 8, 2020
Given the economic shock caused by the Covid-19 pandemic, it is stunning how markets have managed to hit a trough in just 69 days
Rowan Walrath
June 4, 2020
Overjet's purported mission is to help insurance companies and dental health providers improve patient care and spend less money through automation.
By Luke Andrews For Mailonline
June 4, 2020
Mail Online
Scientists found that sleep-deprived flies died after 20 days, half their normal lifespan. But when they were given an antioxidant the sleep-deprived insects lived did not die prematurely.
Rowan Walrath
May 29, 2020
OraSure Technologies is buying the company for $3 million upfront, with an additional $28 million in payments contingent on specific milestones.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.